Vanderbilt University Medical Center to Recruit Up to 1,000 Volunteers for COVID-19 Vaccine Trial

In late July, Vanderbilt University Medical Center (VUMC) will begin recruiting up to 1,000 volunteers in a late-stage study of an experimental COVID-19 vaccine developed by Moderna Inc. in collaboration with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

The randomized, placebo-controlled Phase 3 trial will be open to people 18 years old and older. They will receive two shots of either the vaccine or an inactive placebo and will be followed for two years.

The goals of the study are to determine how effective the vaccine is in protecting against COVID-19 and how long the protection lasts. For more information, contact or

“Vaccine development around COVID-19 is moving at an unprecedented pace due to the remarkable partnerships between academic institutions, the NIH and pharmaceutical industry leaders,” said Buddy Creech, MD, MPH, principal investigator of the NIH-funded Vanderbilt Vaccine and Treatment Evaluation Unit (VTEU).

“We are pressing full speed ahead to provide an answer to this pandemic, while also taking the necessary steps to ensure that new vaccines and therapeutic drugs are both safe and effective,” said Creech, also associate professor of Pediatric Infectious Diseases and director of the Vanderbilt Vaccine Research Program.

The study will be conducted through the VTEU and Vanderbilt’s HIV Vaccine Trials Unit Clinical Research Site, part of the HIV Vaccine Trials Network (HVTN). Spyros Kalams, MD, associate professor of Medicine and Pathology, Microbiology and Immunology, is the HVTN principal investigator.

VUMC is one of several U.S. centers participating in the nationwide Phase 3 trial, which will enroll 30,000 volunteers over the next two months, officials said.

VTEU and HVTN sites are part of the NIAID-supported COVID-19 Prevention Network (CoVPN), which will harness the resources and expertise of national research networks to rapidly evaluate COVID-19 prevention strategies.

“This massive effort to rapidly and safely test COVID-19 vaccines takes advantage of these existing networks, each with multiple clinical research sites and great deal of vaccine and immunology expertise,” Kalams explained. 

The Moderna mRNA vaccine contains genetic material from the spike protein on the surface of SARS-CoV-2, the virus that causes COVID-19. The spike protein enables the virus to bind and fuse with the membrane of certain types of cells in the body, the first step in infection.

VUMC researchers provided laboratory support of a Phase 1 trial of the vaccine in 45 healthy adults. According to a report published Tuesday in The New England Journal of Medicine, the vaccine had no safety concerns and induced anti-SARS-CoV-2 immune responses in all participants.

A Phase 2 study to further evaluate the safety of the vaccine and its ability to elicit an immune response is currently underway in healthy adults.

The Vanderbilt study has been funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services and the Vanderbilt Vaccine and Treatment Evaluation Unit (VTEU) Cooperative Agreement/Grant numbers 1UM1 AI148452-01 and AI148452-01S3.

The Vanderbilt HIV Clinical Trials Unit is supported by NIH grants 5UM1AI069439-15 and 3UM1AI069439-15S1.


WhistlePig + Alfa Romeo F1

SHOREHAM, VT (September 13, 2023) — WhistlePig Whiskey, the leaders in independent craft whiskey, and Alfa Romeo F1 Team Stake are waving the checkered flag on a legend-worthy release that’s taking whiskey to G-Force levels. The Limited Edition PiggyBack Legends Series: Alfa Romeo F1 Team Stake Barrel is a high Rye Whiskey selected by the Alfa Romeo F1 Team Stake drivers, with barrels trialed in their wind tunnel to ensure a thrilling taste in every sip.

The third iteration in WhistlePig’s Single Barrel PiggyBack Legends Series, the Alfa Romeo F1 Team Stake Barrel is bottled at 96.77 proof, a nod to Valtteri Bottas’ racing number, 77, and the precision of racing. Inspired by Zhou Guanyu, the first Chinese F1 driver, this Rye Whiskey is finished with lychee and oolong tea. Herbal and floral notes of the oolong tea complement the herbaceous notes of WhistlePig’s signature PiggyBack 100% Rye, rounded out with a juicy tropical fruit finish and a touch of spice.

Keep readingShow less
by Spectrum Medical Care Center

Nurse Practitioner Ari Kravitz

When I started medical transition at 20 years old, it was very difficult to get the care I needed for hormone replacement therapy because there are very few providers trained in starting hormones for trans people, even though it’s very similar to the hormones that we prescribe to women in menopause or cisgender men with low testosterone.

I hope more providers get trained in LGBTQ+ healthcare, so they can support patients along their individual gender journey, and provide the info needed to make informed decisions about their body. I’ve personally seen my trans patients find hope and experience a better quality of life through hormone replacement therapy.

Keep readingShow less

Descanso Resort swimming pool and lounge area

Descanso Resort, Palm Springs' premier destination for gay men, just received Tripadvisor's highest honor, a Travelers' Choice "Best of the Best" award for 2023. Based on guests' reviews and ratings, fewer than 1% of Tripadvisor's 8 million listings around the world receive the coveted "Best of the Best" designation. Descanso ranked 12th in the top 25 small inns and hotels category in the United States. Quite an accomplishment!

Open less than two years, Descanso Resort offers gay men a relaxing and luxurious boutique hotel experience just minutes away from Palm Springs' buzziest restaurants, nightclubs, and shopping. Descanso has quickly established itself as a top destination for sophisticated gay travelers, earning hundreds of 5-star guest reviews and consistently ranking in Trapadvisor's top positions alongside brother properties Santiago Resort and Twin Palms Resort.

Keep readingShow less